セッション

Concomitant WT1 mutations predicted poor prognosis in CEBPA double-mutated acute myeloid leukemia

[演者] Feng-Ming Tien:1
[著者] Hsin-An Hou:1, Chien-Yuan Chen:1, Wen-Chien Chou:2, Jih-Luh Tang:1, Hwei-Fang Tien:1
1:Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, 2:Departments of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

Analyze 36 fusion genes in 6170 de novo acute leukemia and myeloid neoplasms cases during 14 years

[演者] Xue Chen:1
[著者] Wen Teng:1, Lei Guo:1, Xiaoli Ma:1, Fang Wang:1, Yang Zhang:1, Ying Zhang:2, Ping Zhu:2, Hongxing Liu:1
1:Beijing Lu Daopei Hospital, Beijing, China, 2:Department of Hemotology, Peking University First Hospital, Beijing, China

Genomic landscape of adult mixed phenotype acute leukemia (MPAL)

[演者] Kiyomi Morita (森田 聖美):1,2
[著者] Feng Wang:1, Keyur Patel:1, Carlos Bueso-Ramos:1, Abdallah Abou Zhar:1, Curtis Gumbs:1, Latasha Little:1, Samantha Tippen:1, Rebecca Thornton:1, Marcus Coyle:1, Jianhua Zhang:1, Xingzhi Song:1, Marisela Mendoza:1, Chang-Jiun Wu:1, Steven Kornblau:1, Courtney Dinardo:1, Farhad Ravandi:1, Guillermo Garcia-Manero:1, Elias Jabbour:1, Michael Andreeff:1, Hagop Kantarjian:1, Jorge E. Cortes:1, Marina Konopleva:1, Andrew Futreal:1, Koichi Takahashi (高橋 康一):1
1:The University of Texas MD Anderson Cancer Center, Houston, USA, 2:Department of Hematology and Oncology, The University of Tokyo

Genetic landscape of acute erythroid leukemia

[演者] June Takeda (竹田 淳恵):1,8
[著者] Lee-Yung Shih:2, Kenichi Chiba (千葉 健一):3, Yuichi Shiraishi (白石 友一):3, Yusuke Shiozawa (塩澤 裕介):4, Hideki Makishima (牧島 秀樹):1, Tetsuichi Yoshizato (吉里 哲一):1, Yasunobu Nagata (永田 安伸):5, Akira Hangaishi (半下石 明):6, Ken Ishiyama (石山 謙):7, Akifumi Takaori-Kondo (高折-近藤 晃史):8, Keisuke Kataoka (片岡 圭亮):1, Masashi Sanada (真田 昌):9, Hiroko Tanaka (田中 洋子):3, Kensuke Usuki (臼杵 憲祐):6, Shuichi Miyawaki (宮脇 修一):10, Satoru Miyano (宮野 悟):3, Arnold Ganser:11, Michael Heuser:11, Seishi Ogawa (小川 誠司):1, Felicitas Thol:11, Kenichi Yoshida (吉田 健一):1
1:Dept. of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan, 2:Division of Hematology-Oncology, Chang Gung University, Taoyuan, Taiwan, 3:Human Genome Center, The University of Tokyo, Tokyo, Japan, 4:Dept. of Pediatrics, The University of Tokyo, Tokyo, Japan, 5:Dept. of Translational Hematology and Oncology, Cleveland Clinic, OH, US, 6:Dept. of Hematology, NTT Medical Center, Tokyo, Japan, 7:Dept. of Hematology, Kanazawa University, Kanazawa, Japan, 8:Dept. of Hematology/Oncology, Kyoto University, Kyoto, Japan, 9:Dept. of Advanced Diagnosis, Nagoya Medical Center, Nagoya, Japan, 10:Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan, 11:Dept. of Hematology, Oncology and SCT, Hannover Medical School, Germany

Clinical significance and association of other gene aberrations of PTPN11 mutations in pediatric AML

[演者] Genki Yamato (大和 玄季):1,2,3
[著者] Norio Shiba (柴 徳生):1,3,4, Yusuke Hara (原 勇介):1,2,3, Kentaro Ohki (大木 健太郎):1,3,5, Jun Okubo (大久保 淳):1,3, Myoung-Ja Park (朴 明子):1,3, Manabu Sotomatsu (外松 学):1,3, Hirokazu Arakawa (荒川 浩一):2, Nobutaka Kiyokawa (清河 信敬):3,5, Daisuke Tomizawa (富澤 大輔):3,6, Keizo Horibe (堀部 敬三):3,7, Souichi Adachi (足立 壮一):3,8, Takashi Taga (多賀 崇):3,9, Yasuhide Hayashi (林 泰秀):1,3,10
1:Dept. Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan, 2:Dept. Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan, 3:Japan Children's Cancer Group, Japan, 4:Dept. Pediatrics, Yokohama City University Hospital, Kanagawa, Japan, 5:Natl. Cent. for Child Health and Dev., Tokyo, Japan, 6:Div. Leukemia and Lymphoma, Children's Cancer Center, NCCHD, Tokyo, Japan, 7:Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan, 8:Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 9:Dept. Pediatrics, Shiga University of Medical Science, Shiga, Japan, 10:Japanese Red Cross Gunma Blood Center, Gunma, Japan

詳細検索